SCHEMBL10814397

SCHEMBL10814397

CCCCCCCCOC(=O)OCC(COC(=O)OCCCCCCCC)OCn1cnc2c(SC)nc(N)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.43
▸ HK1 P19367 1/20 0.41
▸ HKDC1 Q2TB90 1/20 0.41
▸ SLC29A1 Q99808 3/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.38
▸ CYP3A4 P08684 8/20 0.37
▸ HIF1A Q16665 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ VCP P55072 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CYP2D6 P10635 7/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10846484 0.96 PDE3A (0.46) CYP2C19HK1HKDC1SLC29A1PDE3A
SCHEMBL9583975 0.88 CYP2C19 (0.43) CYP2C19HK1HKDC1SLC29A1PDE3A
SCHEMBL9584601 0.88 CYP2C19 (0.43) CYP2C19HK1HKDC1SLC29A1PDE3A
SCHEMBL9583247 0.88 CYP2C19 (0.43) CYP2C19HK1HKDC1SLC29A1PDE3A
SCHEMBL10815175 0.88 PDE3A (0.35) CYP2C19HK1HKDC1PDE3ACYP3A4
SCHEMBL10816341 0.86 CYP1A2 (0.51) PDE3ACYP3A4ALDH1A1CYP2D6CYP1A2
SCHEMBL10813165 0.84 PDE3A (0.41) PDE3ACYP3A4HIF1AMEN1ALDH1A1
SCHEMBL9594486 0.83 PDE3A (0.48) CYP2C19HK1HKDC1SLC29A1PDE3A
SCHEMBL10817760 0.82 CYP1A2 (0.48) PDE3ACYP3A4HIF1AMEN1ALDH1A1
SCHEMBL10811445 0.81 PDE3A (0.61) PDE3ACYP3A4HIF1AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0105135-B1 SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS SYNTEX (U.S.A.) INC. (US) 1987-03-18 — — EP disclosed
US-4609661-A HERPES VIRUS SYNTEX (U.S.A.) INC. (US) 1986-09-02 — — US disclosed
US-4556659-A Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1985-12-03 — — US disclosed
EP-0105135-A1 Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents SYNTEX (U.S.A.) INC. (US) 1984-04-11 — — EP disclosed
Send feedback